MMV Board member recognized for contributions to parasitology
MMV wishes to congratulate Prof. Michael A.J. Ferguson, its partner, Board member and a prominent life scientist who has been awarded an Honorary Membership in the British Society for parasitology.
Prof. Ferguson is Regius Professor of Life Sciences and Associate Dean for Research Strategy at the University of Dundee in Scotland. He helped to build the Drug Discovery Unit (DDU) at the university which works with partners to combat neglected diseases such as malaria.
In 2013, MMV and the DDU jointly discovered and delivered the candidate drug M5717 (formerly known as DDD107498), a novel and potent antimalarial compound which is active against multiple stages of the parasite lifecycle and inhibits protein synthesis, a process necessary for the parasite’s survival. In 2014 the compound was awarded MMV’s Project of the Year and in 2015, it was assigned to Merck KGaA. The compound has completed first-in-human (FiH) and volunteer infection study (VIS) trials and is planned to start patient studies at the end of 2022.
“We are delighted to hear about Prof. Ferguson’s well deserved Honorary Membership in the British Society for Parasitology,” said Dr David Reddy, MMV’s CEO. “As an active member of the MMV Board, his contribution to our organization is invaluable. We look forward to our continued collaboration.”